Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

DrContango Free

09/20/18 9:49 PM

Post #201

MEDTRONIC TO ACQUIRE MZOR!!!

Medtronic Plc, agreed to buy Mazor Robotics Ltd., a maker of robotic guidance systems, in a $1.64 billion cash deal to strengthen its position in technology for spine surgery.

Medtronic agreed to pay $58.50 per American depositary share for the stock in Mazor that it doesn’t already own, the companies said in a joint statement Thursday. Medtronic previously held an 11 percent stake in the Israel-based company, according to Bloomberg data. The boards of directors of both companies have unanimously approved the transaction. The deal is expected to close in Medtronic’s third quarter.

"We believe robotic-assisted procedures are the future of spine surgery, enhancing surgeons’ abilities to perform complex procedures with greater precision, consistency and control,” Geoff Martha, executive vice president and president of the Restorative Therapies Group at Medtronic, said in the statement.

https://finance.yahoo.com/news/medtronic-agrees-buy-mazor-robotics-231902512.html

Doc

black diamond Free

03/19/18 7:56 PM

Post #200

Re: #199: @semi_infinite - What do you think of Globus's robotic system?

MAZOR!!!

semi_infinite Free

03/06/18 3:22 PM

Post #199

Re: #198: @Phaeton - MAZOR is ready for the next leg up

What do you think of Globus's robotic system?

Phaeton

02/19/18 9:18 PM

Post #198

MAZOR is ready for the next leg up to $65.00.

Phaeton

01/25/18 9:21 PM

Post #197

Re: #196: @KOGT - talk about a low float. 27 orders in

That is why Sales have been shifted to Medtronic world wide. Mazor responsible for R&D and production.

This shift started to take place in October or November. Medtronic will have sales force trained and in place during Q1 or Q2 18.

Remember Mazor didn’t have a big sales staff.
Great things in the future.

KOGT

01/25/18 11:34 AM

Post #196

Re: #194: @Phaeton - You are correct. Right now you have

talk about a low float. 27 orders in 4th qtr!!!!

treboriluap Free

12/07/17 7:26 AM

Post #195

Re: #192: @Phaeton - Mazor Robotics Confirms CEO Was Questioned as Part

Thanks. I had not found that release. Even if true, That’s CEO’s personal problem. Long run, we’ll be Fine.

Phaeton

12/06/17 8:29 PM

Post #194

Re: #193: @black diamond - Hasn’t helped stock price regardless

You are correct. Right now you have end of years tax selling so I don’t see us climbing much until mid January 2018 or early February with 4th quarter earnings.

Mazor really over achieved this year and the PPS got heated. Hitting $65.00 was fun. Now if one had the mind set to sell at $65.00.

I actually thought about it offsetting some loses in some other equities. My view has always a buy and hold but if you are a swing trader this is a great equity to ride the up’s and downs as there will be some every quarter. Look back over the last 12 months and you can chart them out.

The question of the insider trading allegations should not concern you if you have confidence in the product, the board of director and the partnership with Medtronic

The board would have fired Ori Hadomi immediately if there was any wrong doing by anybody involved with Mazor.

black diamond Free

12/06/17 4:49 PM

Post #193

Re: #192: @Phaeton - Mazor Robotics Confirms CEO Was Questioned as Part

Hasn’t helped stock price regardless

Phaeton

12/06/17 2:52 PM

Post #192

Mazor Robotics Confirms CEO Was Questioned as Part of Israel Insider Trading Investigation
BY MT NEWSWIRES — 12/05/2017
10:56 AM EST, 12/05/2017 (MT Newswires) -- Mazor Robotics (MZOR) confirmed Tuesday that its CEO, Ori Hadomi, has been questioned by the Israeli Securities Authority in connection with an investigation of insider trading related to third parties.

The company said in a regulatory filing that both a search of Mazor's offices and Hadomi's interrogation were conducted on the same date in May, noting that, to its knowledge, since then Hadomi was not called for any further questioning.

"Mazor and Mr. Hadomi intend to continue to cooperate with the ISA in the future, to the extent required. Mr. Hadomi continues to operate in his capacity as Mazor's Chief Executive Officer," Mazor said. "The board of directors of Mazor have expressed their full support and confidence in Mr. Hadomi and in his continuous leadership of Mazor and its development."

Price: 55.10, Change: -0.63, Percent Change: -1.14

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2017 Midnight Trader, Inc. All rights reserved.

Phaeton

12/04/17 8:34 PM

Post #191

Noise today regarding Mazor. The claim is that last May or June raid by Israeli regulators that Ori Hadomi had his cell phone taken along what his computer. I call this information FUD unless the Israeli regulators issue a statement regarding what their findings were.

If the Mazor Board of Directors felt the need to remove CEO Ori Hadomi they would have done so by now. The Board of Directors of Mazor would not play around and keep a liability on their payroll as CEO / President.

My view is that Ori Hadomi is doing a great job and his communications have been on target. It does not seem plausible that he leaked any information about their partnership with Medtronic that influenced buyers or sellers of Mazor shares.

If he is found guilty then the board will act within their fiduciary duties and fire him from the company.

Anytime a stock goes from $20.50 this time last year to a high of $65.00 last month one wonders who what and why is driving the rise and if there is information being leaked.

Hopefully we find there is nothing but FUD here.

I am long on Mazor.

treboriluap Free

12/04/17 11:19 AM

Post #190

Re: #189: @Phaeton - That was nice CLOSE not nice clothes...... my bad.

A few Nice Closes, then I'll be able to afford nice Clothes! This dip reflects a dip's opinion on it being "fully valued," whatever that means. Amazon was "fully valued" eons ago, but that has not stopped the euphoria from pushing it into the stratosphere. MZOR probably running a year ahead of itself in value, while AMZN is running about 5 years ahead. My wife has AMZN; I'll stick with MZOR. I still thing Medtronic will eventually take ownership @ about $80. Now THAT's fully valued.

Phaeton

11/27/17 11:01 PM

Post #189

Re: #187: @Phaeton - Nice clothes for the week. Mazor is a

That was nice CLOSE not nice clothes...... my bad.

radly

11/27/17 9:37 PM

Post #188

Re: #187: @Phaeton - Nice clothes for the week. Mazor is a

With the share price rising they can probably afford to buy some nice clothes this week. Probably some real nice suits and ties. lol

Phaeton

11/24/17 6:53 PM

Post #187

Nice clothes for the week. Mazor is a remarkable company. The best is yet to come in the partnership with Medtronic.
The great thing is that the company has the ability to do another partnership deals for different types of surgery outside of spinal. That will be the next area of growth for Mazor.

TREND1

11/19/17 5:36 PM

Post #186

MZOR 30 MIN DAY WEEK

TREND1

11/19/17 1:58 PM

Post #185

Re: #173: @Phaeton - Great article on why this company has a

This looks like a very good stock.

TREND1

11/19/17 1:26 PM

Post #184

Earnings Per Share (EPS) = $ -18.67M

TREND1

11/19/17 1:25 PM

Post #183

Profit/Loss = $ -18.67M

TREND1

11/19/17 1:24 PM

Post #182

Market Cap =$ 1.54B

TREND1

11/19/17 1:22 PM

Post #181

MZOR DAY

matt24d

11/08/17 8:31 AM

Post #180

Re: #179: @radly - What does that mean "Market positioning themselves"?

Yes but the stock was up $13 in the last few weeks. It ran from $53 to almost $66 so now its needs to consolidate some gains. As far as my statement it means the big money is positioning themselves in the stock. I think you have some taking profits and others using the dip to add shares. Remember this has a small OS and float. Does not take much to move it either direction.

radly

11/07/17 5:52 PM

Post #179

Re: #178: @matt24d - Its just the market positioning themselves. I think

What does that mean "Market positioning themselves"?

The dip has been more than just today. Down $6 in the last week.

Thanks

matt24d

11/07/17 5:20 PM

Post #178

Re: #177: @radly - Revenues Doubles yet the share price sinks.

Its just the market positioning themselves. I think the dip today was to shake out loose hands. This one rebounds soon. They are setting themselves up for real growth. IMO I think its only a matter of time before Medtronic makes an all out play for this company. Also it was only down .98 for the day not bad at all.

radly

11/07/17 5:09 PM

Post #177

Revenues Doubles yet the share price sinks. What's up with that?

Adrock

11/02/17 8:21 PM

Post #176

Re: #174: @radly - Excuse me, How low can she go??? Down

All good buy more!

BullMarket34 Free

11/02/17 7:10 PM

Post #175

Re: #174: @radly - Excuse me, How low can she go??? Down

Healthy pullback

radly

11/02/17 6:39 PM

Post #174

Re: #172: @radly - How high can she go???

Excuse me, How low can she go??? Down almost $8 in 2 days!

Phaeton

10/31/17 10:37 PM

Post #173

Great article on why this company has a lot of room to run with $MDT as a partner.

https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other

Excerpt:
The $72 million invested by Medtronic (as of Sept 2017) has allowed Mazor to scale at a much faster rate then they ever would have without the capital.

Excerpt:
Medtronic also has warrants allowing them to buy another 1.2 million shares, which could bring their total investment to $125 million, or 14% ownership of the company.

Excerpt:
It's Not Just About the Money
It's not just the capital though, Mazor could get funding from anyone. What they received with Medtronic's money is an instant world-class sales organization that provides contacts and validation in the U.S.

Trust me, getting a product launched in the U.S. without a sales team, marketing and validation is virtually impossible.

This partnership is a win-win for both companies.

They are two companies that need each other. Mazor doesn't have the sales infrastructure in place and Medtornic's Spine division is a mess.

radly

10/31/17 10:25 PM

Post #172

How high can she go???

BudFoxWallStreet Free

10/31/17 5:54 PM

Post #171

It looks like the medtronic and mazor partnership is a win-win for both. Mazor is a legit company, not a fairytale like some of the other robotic surgery companies. Still big room for growth.

https://www.medtechy.com/the-ticker/articles/2017/medtronic-and-mazor-robotics-need-each-other

biotechnician Free

10/30/17 11:22 PM

Post #170

WOW, MZOR Market cap only 1.5 Billion and ISRG's is 41 Billion. MZOR stock price can Double and still just be 3 Billion MC.

wshaw14

10/20/17 4:58 AM

Post #169

Re: #120: @tootalljones - Tre, i meant yes on our little gem

LOL, I thought that was you on that other board. Now with a little DD it is confirmed. I enjoyed reading the posts. Johnnyola

Phaeton

10/15/17 10:52 PM

Post #168

Mazor on the Move with new hire.

Great read on Israeli company Mazor Robotics.

https://finance.yahoo.com/news/mazor-robotics-appoints-medical-device-083000027.html

Currently there operating systems is based on spinal surgery but they are going to expand into other areas.

He will lead the implementation of our strategies to develop Mazor’s business beyond our current spine focus as we pursue our goal of being the leader in image based medical robotics,” commented Mr. Hadomi.

semi_infinite Free

10/14/17 10:09 AM

Post #167

Re: #162: @semi_infinite - trxc Senhance platform is going through 510k process.

TRXC - +80% AH on FDA 510k clearance. Ahead of schedule that I anticipated.

"FDA concluded that these study data, supported by real-world evidence, along with performance testing under simulated use and worst-case scenario conditions, demonstrated the substantial equivalence of the Senhance System to the da Vinci Si IS3000 device for gynecological and colorectal procedures."

Phaeton

10/01/17 12:24 PM

Post #166

Re: #165: @treboriluap - In for 4K.

Same here in for 4,000 shares. Great company with a great future with Medtronic. They can also partner with other companies.

MDT owns 15% of Mazor.

treboriluap Free

09/25/17 1:18 PM

Post #165

Re: #164: @tootalljones - Great success for you with cteq and mazor.

In for 4K.

tootalljones Free

09/24/17 10:55 AM

Post #164

Re: #163: @treboriluap - Thanks much for this post. Initially dismayed when

Great success for you with cteq and mazor. We do not need a gold bull market whatsoever for a fast double but we may get one as a surprise. Read my posts on the board itself.

treboriluap Free

09/24/17 8:13 AM

Post #163

Re: #154: @tootalljones - tre, i have moved into PVG. *still like

Thanks much for this post. Initially dismayed when I read on the “other” stock that Johnny had moved on. Just got back from UK and had not read this board. I am only surprised you went “all or nothing” from the other to PVG. That said, I can see where a good gold stock would be a great hedge against an overheated market and a 20 trillion dollar debt currency. Will look very close at PVG today for a possible Monday investment. I’m fairly loaded with mzor and Iva... profits. Am well aware of how good your exit timing was from ctix and avxl. BTW, doing very well on Friedland’s cteqf, but liquidity constrained, so only have 10 k. Gl w/PVG.

semi_infinite Free

09/22/17 11:05 AM

Post #162

Re: #161: @smartini - @nowlurking: can you please provide more details? thanks

trxc Senhance platform is going through 510k process. The usual time frame after the response letter is 30-60 days. It is ce marked and has 20 installations, most of them in EU. One in Florida hospital for their r&d program. 510k clearance will result in US sales no doubt. How well the system sells in the US post clearance is open question since isrg has the market. Senhance competes by allowing existing lap devices to be used with it which is a plus and much more economical than the proprietary tools that one has to use with Da Vinci. SYK and NVDQ can be used with Senhance as examples. IMO haptics is important and something Da Vinci does not have yet. The other platform that they have worked on is a single port robotised version of their spider lap system called Surgibot. That was rejected in the past because the FDA ruled that it is too different than the spider to go through the 510k route. isrg is also worked on single port robot and I haven't looked into the stasis of that.

smartini

09/22/17 5:27 AM

Post #161

Re: #160: @semi_infinite - trxc - gap fills as expected. Post

@nowlurking: can you please provide more details? thanks

semi_infinite Free

09/20/17 1:55 PM

Post #160

Re: #153: @semi_infinite - trxc - sold half of what I bought

trxc - gap fills as expected. Post 9/18 PR that company has filed early response to FDA AI request letter as part of 510k review process. 30 day clock starts upon FDA receipt of response.

Phaeton

09/20/17 12:11 PM

Post #159

Nice to see that the company earned their European CE marking.
New highs today. I guess we have a winner.

wiltonio

09/19/17 6:17 AM

Post #158

Migdal Insurance & Financial Holdings Ltd. has filed a new 13G, reporting 4.92% ownership in $MZOR - https://fintel.io/soh/us/mzor/migdal-insurance-financial-holdings and https://fintel.io/i/migdal-insurance-financial-holdings

mazlat10

09/17/17 2:37 PM

Post #157

Re: #155: @Phaeton - New SEC filing that is good for Mazor.

RIGHT ON

Phaeton

09/17/17 9:32 AM

Post #156

You got part of your wish. Medtronic now owns 16% of Mazor. The future looks very brite.

Phaeton

09/17/17 9:28 AM

Post #155

New SEC filing that is good for Mazor. It is a SEC form 13G that shows that Medtronic (MDT) now owns 16% of Mazor. This is the next phase of their agreement. This is good for shareholders. Added stability.

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12283145&RcvdDate=9/15/2017&CoName=MAZOR%20ROBOTICS%20LTD.&FormType=SC%2013G/A&View=html

tootalljones Free

09/16/17 9:56 AM

Post #154

Re: #124: @treboriluap - Thanks much for the thoughts. Hadn't personally thought

tre, i have moved into PVG. *still like the other one of course. Taking a serious position and will add next week to it. Pretium. Expecting another double (or more) over next 12 months. Peter Arendas on Seeking Alpha just said he is finally buying, which means he cannot resist any longer. I am very familiar with management and have followed Quartermain for over a decade. I have wanted to own this company (mildly) for years, provided the story panned out. It is panning out. Confident the stock will be in double digits by year end, which is no great return from here but Arendas said he is looking for 15 by year end, a tremendous year end return. I think he is a tad early but this number will be obtained over time. Do the DD. It is finally going to happen as they are on the launching pad and simply must go higher. The market will be forced to believe. Their studies were done with POG at 1100, but costs have moved up of course too. I see no reason to be in avxl, and still read the board fwiw...

semi_infinite Free

09/13/17 10:26 AM

Post #153

Re: #143: @semi_infinite - TRXC making a move ... I didn't think

trxc - sold half of what I bought to cover cost basis today. Seems it is moving a little fast and leaving behind gaps. Look back of historic prices suggest all gaps so far have been filled.

Phaeton

08/30/17 10:25 PM

Post #152

Great day for Mazor. MDT jumped the shark by 6 months. I hope that Mazor stays independent for many years. Happy to have MDT buy into the company but lets stay independent.

Older

Mazor Robotics (MZOR)

Followers	13	Posters	39
Posts (Today)	0	Posts (Total)	201
Created	01/27/13	Type	Free
Moderators

Mazor Robotics is a leading innovator in spine surgery—inspiring the art of surgery with robotic guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and OR staff. Mazor Robotics' flagship Renaissance™ Surgical Guidance System is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art robotic-guided procedures that raise the standard of care with better clinical outcomes. Based on surgeons' experience with SpineAssist® in thousands of procedures worldwide (over 15,000 implants), Renaissance™ Surgical Guidance System is powered by clinically validated technology. Via Renaissance's intuitive interface, preoperative planning in a virtual 3D environment creates a surgical blueprint for state-of-the-art robotic-guided surgery. Renaissance™ easily integrates into OR workflows, providing the highest level of accuracy with less radiation for deformities, revisions, and minimally invasive surgeries. For peer-reviewed publications on Mazor Robotics' technologies, including a recent 14-center study demonstrating 98% accuracy in hundreds of patients (see Peer Review Library). The system's quick learning curve enables surgeons to leap over the barriers of performing challenging cases and approaches such as minimally invasive surgeries, which are notorious for their learning curve, suboptimal outcomes, higher radiation levels and longer operation times when performed freehand. Mazor Robotics' surgical guidance technology has been successfully used in a wide variety of spinal procedures--from routine cases to the most complex cases. Many of these cases would not even be attempted without Mazor Robotics' surgical guidance technology. The Company's pipeline includes innovative products that will reshape the art of surgery. Among some of these developments are a unique, minimally invasive spinal stabilization procedure which is enabled by Renaissance, an intraoperative 3D imaging system which is an add-on to C-arms (operating room imaging systems), and expanding clinical applications such as cranial procedures, ie, cranial biopsies and deep brain stimulation implant placements).

MZOR Latest News

No Recent News Available for this company!

More MZOR News

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Mazor Robotics (MZOR)

MZOR Latest News